Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Johnson & Johnson (

Johnson & Johnson proposes $8.9 billion payout to settle talcum powder lawsuits

A subsidiary of the company will re-file for Chapter 11 bankruptcy protection and seek court approval for a plan that would result in one of the largest product-liability settlements in U.S. history.

Chicago Sun-Times

Dow Jones Futures: AI Stock Keeps Sliding; Johnson & Johnson Rises

Futures: The indexes held up OK Tuesday amid recession fears, but breadth was weak. AI stock C3.ai kept falling overnight. J&J stock rose..

Investors Business Daily

As states start to get opioid settlement cash, few are sharing how they spend it

All told, drugmakers and distributors will pay over $50 billion to communities harmed by opioids. An investigation finds that only a dozen states are letting the public see how they use the money.

WEKU

From analysis to the latest developments in health,
read the most diverse news in one place.

J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out

Johnson & Johnson ducked out of the RSV vaccine race Wednesday, leaving Pfizer, GSK and Moderna to duke it out.

Investors Business Daily

Victory over big pharma opens door to cheaper tuberculosis drugs

India’s patent office turns down bedaquiline extension to Johnson & Johnson, clearing the way for generic versions

The Guardian - UK

The Strongest Pharma Stock This Week

Tighter bank lending and the Fed’s continued fight against inflation will likely push the economy into a recession this year. In this scenario, investors can look to invest in the pharma giant Johnson & Johnson (JNJ), given its financial strength, reliable dividend payments, and solid growth prospects. Read more….

StockNews.com

Want to Retire a Millionaire? 2 Stocks to Buy Now

The recent bank failures have increased the likelihood of a recession, with many economists increasing the odds of an economic slump in the next 12 months. Amid this backdrop, investors could buy fundamentally strong stocks, Johnson & Johnson (JNJ) and Pfizer (PFE), which could help retire a millionaire. Read on.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

This Big Pharma Stock Is a Clear Buy in 2023

With interest rates expected to be higher than originally anticipated and fears of a looming recession weighing heavily on investors’ decisions, the stock market is expected to remain under pressure this year. Amid this backdrop, it could be wise for investors to invest in Johnson & Johnson (JNJ) due to…

StockNews.com

3 Powerhouse Stocks to Buy in 2023

As the Fed is expected to raise interest rates higher than expected, the revived recession fears will keep the stock market under pressure in the upcoming months. Thus, it could be wise to scoop up shares of high-quality businesses, such as Johnson & Johnson (JNJ), Humana Inc. (HUM), and AutoZone,…

StockNews.com

1 Stock to Buy for Safety in This Volatile Market

With the Fed anticipating higher interest rate hikes than previously expected, the stock market is expected to remain volatile in the upcoming months. Given its strong balance sheet, brand recognition, and solid dividend payouts, it could be safe to invest in Johnson & Johnson (JNJ). Read more….

StockNews.com

How To Use Covered Calls To Get 17% Annualized Return On JNJ Stock

Selling the May 155 call option generates an income of 3.42% in just over two months, equaling around 17% annualized.

Investors Business Daily

Hundreds more tech, life science layoffs jolt East Bay, San Francisco

BERKELEY, Calif. — Hundreds more layoffs affecting tech and life science jobs in the Bay Area have been disclosed by companies in what has morphed into a steady drumbeat of local staffing reductions in the wobbly sectors.

Tribune News Service

Appeals court clears the way for more lawsuits over Johnson's Baby Powder

A U.S. appeals court has dismissed the bankruptcy case filed by a Johnson & Johnson spinoff company. Around 40,000 cancer patients have filed suit, alleging the powder was contaminated with asbestos.

WEKU

Why inventing a vaccine for AIDS is tougher than for COVID

The 4-decades long effort to create an AIDS vaccine suffered a blow with news that a vaccine in a late stage trial was discontinued because results showed it to be ineffective. What are the obstacles?

WEKU

Get all your
news in one place.

100’s of premium titles.
One news app.

Sports Illustrated

What on Earth Is Aaron Rodgers Talking About?

The Packers quarterback gets asked about trade rumors, calls out woke culture, Big Pharma.

Investors Business Daily

Dow Jones Falls 200 Points With 8 Key Earnings Movers; Microsoft Earnings Due

The Dow Jones Industrial Average fell 180 points Tuesday as J&J and Verizon reported earnings. Microsoft earnings are due out after the stock market close.

The Independent UK

J&J subsidiary to pay $9.75M to resolve kickback allegations

Federal prosecutors say a subsidiary of health care company Johnson & Johnson has agreed to pay nearly $10 million to settle allegations that it violated federal and state law by providing free products to a surgeon

Investors Business Daily

Pharmaceutical Stocks Come Close To Cracking A Multibillion-Dollar RSV Vaccine Market

Big Pharma stalwarts are on the brink of launching the first-ever RSV vaccines, potentially enriching the pharmaceutical stocks.

Get all your
news in one place.

100’s of premium titles.
One news app.

Fortune

A guide to purchasing stock in a Fortune 500 company

The steps to purchase a Fortune 500 stock and why they can be a valuable part of your portfolio.

StockNews.com

The 4 Most Attractive Long-Term Stock Picks

With the Fed expected to keep rates higher throughout this year, the odds of the economy tipping into a recession are rising. Amid ongoing macroeconomic uncertainties, investors may consider buying companies with reliable performance over the years for solid long-term returns. To that end, Pfizer (PFE), Johnson & Johnson (JNJ),…

Fortune

The 'Kraken' COVID variant taking hold in the U.S. Here's how many vaccine shots there are—and what experts recommend to protect yourself

The highly transmissible 'Kraken' COVID variant is here. Experts say getting boosted is your best protection.

Fortune

Vaccines are not making COVID strains like 'Kraken' stronger

Scientists say there is no evidence to suggest that vaccinations are making COVID "stronger" and that mutations are a normal part of virus evolution.

StockNews.com

1 Dividend Stock to Buy Now and Retire on Later

Johnson & Johnson (JNJ) continued its business momentum in the third quarter of fiscal 2022, driven by steady demand for its products and innovative, advancing portfolio and pipeline. Moreover, the company has a record of raising its dividend for 60 consecutive years. Amid the current uncertain market conditions, this fundamentally…

The Independent UK

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

Investors Business Daily

There's A New World Order As 4 Big Stocks Like Tesla Fall To Pieces

Want to see just how much stocks like Tesla have fallen to pieces? Just look at the new top 10 most valuable S&P 500 firms.

1 … 7 8 9 10

People

Dipanjan BanchurSince

722 stories

Pat McAfee

625 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations